2021
DOI: 10.4067/s0716-10182021000300423
|View full text |Cite
|
Sign up to set email alerts
|

Síndrome hemofagocítico: Caracterización clínica y seguimiento de una cohorte pediátrica chilena

Abstract: Los autores declaran no tener conflicto de intereses. Este estudio no cuenta con financiamiento.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
1
0
2

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 26 publications
0
1
0
2
Order By: Relevance
“…Hemophagocytic lymphohistiocytosis can be primary or secondary. The former may occur as familial HLH or as part of certain primary immune deficiencies, while the latter can be triggered by a wide variety of infectious, autoimmune, malignant and other conditions [2].…”
Section: Introductionmentioning
confidence: 99%
“…Hemophagocytic lymphohistiocytosis can be primary or secondary. The former may occur as familial HLH or as part of certain primary immune deficiencies, while the latter can be triggered by a wide variety of infectious, autoimmune, malignant and other conditions [2].…”
Section: Introductionmentioning
confidence: 99%
“…La incidencia global no se encuentra definida; países como Estados Unidos de América reportan una incidencia de uno por 100 000 habitantes, en América latina no se ha registrado la tasa de incidencia, pero se tienen reportes de pacientes en los que el síndrome se relaciona con infecciones virales 2 . La mortalidad global es del 95 % si no se recibe tratamiento y del 40 % con el tratamiento oportuno.…”
Section: Introductionunclassified
“…La mortalidad global es del 95 % si no se recibe tratamiento y del 40 % con el tratamiento oportuno. En América Latina algunos estudios describen una mortalidad del 35 % 2 .…”
Section: Introductionunclassified